Stock Market Impact: Shares dropped ~2% in after‑hours trading following the announcement of a $500 million public stock offering.
Listed Companies and Sectors: Tango Therapeutics Inc., a clinical‑stage biotechnology firm focusing on synthetic lethality cancer therapies, is raising capital.
Investment Flows: The offering will be fully underwritten by the company; underwriters have a 30‑day option to purchase up to an additional $75 million of shares, potentially increasing equity inflow.
Interest Rates, Inflation, Liquidity: No mention of monetary policy or liquidity measures.
Fiscal or Monetary Policy: No fiscal or monetary policy announcements.
